2-氯-5-氯磺酰基苯磺酰胺 | 61450-06-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-氯-5-氯磺酰基苯磺酰胺
• 英文名称: 4-chloro-3-sulfamoylbenzenesulfonyl chloride
• 英文别名: 4-Chlor-3-sulfamoyl-benzolsulfonsaeurechlorid；4-Chlorsulfonyl-2-sulfamoylchlorbenzol；4-Chlor-3-sulfamoylbenzolsulfonylchlorid；6-chloro-3-chlorosulfonyl-benzenesulfonamide；4-Chloro-3-sulphamoylbenzenesulphonyl chloride
• CAS: 61450-06-4
• 化学式: C₆H₅Cl₂NO₄S₂
• 分子量: 290.148
• InChiKey: CADAUKUITLKLMI-UHFFFAOYSA-N

物化性质

• 熔点：
  186-187°C
• 溶解度：
  可溶于DMSO（少许）、甲醇（少许）

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  111
• 氢给体数：
  1
• 氢受体数：
  5

安全信息

• 包装等级：
  III
• 危险类别：
  8
• 危险性防范说明：
  P260,P264,P280,P301+P330+P331,P303+P361+P353,P304+P340,P305+P351+P338,P310,P363,P405,P501
• 危险品运输编号：
  3261
• 危险性描述：
  H314

反应信息

• 作为反应物：
  描述：

  2-氯-5-氯磺酰基苯磺酰胺 在 sodium carbonate 、 三乙胺 作用下， 以 水 、 丙酮 为溶剂， 反应 20.33h， 生成 1-<(4-chloro-3-sulfamoylphenyl)sulfonyl>piperazine
  参考文献：
  名称：

  o-Chlorobenzenesulfonamidic derivatives of (aryloxy)propanolamines as .beta.-blocking/diuretic agents

  摘要：

  A series of compounds 1b-f, 2b-f, and 3b-f having an o-chlorobenzenesulfonamidic diuretic moiety variously linked to the nitrogen side chain of the beta-blocking (aryloxy)propanolamine pharmacophore were prepared and tested for their beta1-adrenoceptor affinity. For all the active compounds, beta-blocking and diuretic activities were investigated in rats; the structure-activity relationships are discussed Some of the compounds displayed varying levels of both properties and among these, compounds 1c and 2c have been chosen for further development.

  DOI：

  10.1021/jm00053a020

文献信息

• SUBSTITUTED N-AMINOMETHYLENE SULFONAMIDES, PRODUCTION AND USE THEREOF AS MEDICAMENTS
  申请人：SCHOENAFINGER Karl

  公开号：US20080069851A1

  公开（公告）日：2008-03-20

  Disclosed are compounds of the general formula (I), with the definitions of the substituents R 1 to R 5 , A and X being detailed in the text, and to their physiologically tolerated salts, to processes for preparing these compounds and to the use thereof as inhibitors of hormone-sensitive lipase (HSL).

  本发明揭示了一般式（I）的化合物，其中定义了取代基R1到R5，A和X的详细信息，以及其生理耐受盐的制备过程，以及它们作为激素敏感性脂肪酶（HSL）抑制剂的用途。
• Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
  申请人：SCHERING CORPORATION

  公开号：EP0088350A1

  公开（公告）日：1983-09-14

  The compounds of the present invention are compounds of the formula and the pharmaceutically acceptable esters and salts thereof wherein R' and R2 independently are hydrogen or lower alkyl; the group is one of the structures II to VIII specified in the description, one of R3, R4 and R5 is a group Z-(CH2)0-6-' wherein Z is selected from Z' to Z10 being as defined in the description and the other of the groups R3, R4 and R5 are as also defined. The compounds are useful as antihypertensive agents, in the treatment of congestive heart failure and glaucoma. Their preparation and pharmaceutical compositions are disclosed.

  本发明的化合物是如下式的化合物 及其药学上可接受的酯和盐 其中 R' 和 R2 分别为氢或低级烷基；基团 是描述中规定的结构 II 至 VIII 之一，R3、R4 和 R5 中的一个是基团 Z-(CH2)0-6-'，其中 Z 选自描述中定义的 Z' 至 Z10，基团 R3、R4 和 R5 中的另一个也如定义。这些化合物可用作降压药、治疗充血性心力衰竭和青光眼。已公开了它们的制备方法和药物组合物。
• SULFONAMIDE COMPOUND OR SALT THEREOF
  申请人：Taiho Pharmaceutical Co., Ltd.

  公开号：EP3466934A1

  公开（公告）日：2019-04-10

  The present invention provides a novel sulfonamide compound having a ribonucleotide reductase inhibitory activity or a salt thereof, and a pharmaceutical composition containing the same as an active ingredient. A compound represented by Formula (I) [wherein, X1 represents an oxygen atom or the like; X2 represents an oxygen atom; X3 represents -NH-; X4 represents a hydrogen atom or the like; R1 represents -C(R11)(R12)- or the like; R11 and R12 are the same or different and each represents a hydrogen atom or the like; R2 represents an optionally substituted C6-C14 aromatic hydrocarbon group or the like; R3 represents an optionally substituted C6-C14 aromatic hydrocarbon group or the like; R4 represents a hydrogen atom or the like] or a salt thereof.

  本发明提供了一种具有核糖核苷酸还原酶抑制活性的新型磺酰胺化合物或其盐，以及含有该化合物作为活性成分的药物组合物。 由式(I)代表的化合物[其中，X1代表氧原子或类似物；X2代表氧原子；X3代表-NH-；X4代表氢原子或类似物；R1代表-C(R11)(R12)-或类似物；R11和R12相同或不同且各自代表氢原子或类似物；R2代表任选取代的C6-C14芳烃基团或类似物；R3代表任选取代的C6-C14芳烃基团或类似物；R4代表氢原子或类似物]或其盐。
• ANTITUMOR AGENT
  申请人：Taiho Pharmaceutical Co., Ltd.

  公开号：EP3718545A1

  公开（公告）日：2020-10-07

  The present invention provides a method of enhancing an antitumor effect by a compound strongly inhibiting ribonucleotide reductase (RNR) or a salt thereof. A combination formulation involving combined administration of a sulfonamide compound represented by Formula (I) [In the formula, X1 represents an oxygen atom or the like; X2 represents an oxygen atom; X3 represents -NH-; X4 represents a hydrogen atom or the like; R1 represents -C(R11) (R12)- or the like; R11 and R12 are the same or different and each represents a hydrogen atom or the like; R2 represents an optionally substituted C6-C14 aromatic hydrocarbon group or the like; R3 represents an optionally substituted C6-C14 aromatic hydrocarbon group or the like; R4 represents a hydrogen atom or the like] or a salt thereof, having RNR inhibitory activity, and other antitumor agent(s).

  本发明提供了一种通过强抑制核糖核苷酸还原酶（RNR）的化合物或其盐增强抗肿瘤效果的方法。 一种组合制剂涉及联合给药由式(I)代表的磺酰胺化合物[式中，X1代表氧原子或类似物；X2代表氧原子；X3代表-NH-；X4代表氢原子或类似物；R1代表-C(R11)(R12)-或类似物；R11和R12相同或不同，各自代表氢原子或类似物；R2代表任选取代的C6-C14芳烃基团或类似物；R3代表任选取代的C6-C14芳烃基团或类似物；R4代表氢原子或类似物]或其盐，具有RNR抑制活性，以及其他抗肿瘤剂。
• Sulfonamide compound or salt thereof
  申请人：Taiho Pharmaceutical Co., Ltd.

  公开号：US10889555B2

  公开（公告）日：2021-01-12

  The present invention provides a novel sulfonamide compound having a ribonucleotide reductase inhibitory activity or a salt thereof, and a pharmaceutical composition containing the same as an active ingredient. A compound represented by Formula (I) [wherein, X1 represents an oxygen atom or the like; X2 represents an oxygen atom; X3 represents —NH—; X4 represents a hydrogen atom or the like; R1 represents —C(R11)(R12)— or the like; R11 and R12 are the same or different and each represents a hydrogen atom or the like; R2 represents an optionally substituted C6-C14 aromatic hydrocarbon group or the like; R3 represents an optionally substituted C6-C14 aromatic hydrocarbon group or the like; R4 represents a hydrogen atom or the like] or a salt thereof.

  本发明提供了一种具有核糖核苷酸还原酶抑制活性的新型磺酰胺化合物或其盐，以及含有该化合物作为活性成分的药物组合物。 由式(I)代表的化合物[其中，X1代表氧原子或类似物；X2代表氧原子；X3代表-NH-；X4代表氢原子或类似物；R1代表-C(R11)(R12)-或类似物；R11和R12相同或不同且各自代表氢原子或类似物；R2代表任选取代的C6-C14芳烃基团或类似物；R3代表任选取代的C6-C14芳烃基团或类似物；R4代表氢原子或类似物]或其盐。